Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular matrix stiffness regulates degradation of MST2 via SCF βTrCP. | Biochim Biophys Acta Gen Subj | 2022 | 36044955 | PubTator, text mining | PubMed |
| Construction of a prognostic risk model based on apoptosis-related genes to assess tumor immune microenvironment and predict prognosis in hepatocellular carcinoma. | BMC Gastroenterol | 2022 | 36028814 | PubTator, text mining | PubMed |
| MicroRNA-7a2 Contributes to Estrogen Synthesis and Is Modulated by FSH via the JNK Signaling Pathway in Ovarian Granulosa Cells. | Int J Mol Sci | 2022 | 35955699 | PubTator, text mining | PubMed |
| Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis. | World J Clin Cases | 2022 | 35949853 | PubTator, text mining | PubMed |
| Role of m6A writers, erasers and readers in cancer. | Exp Hematol Oncol | 2022 | 35945641 | PubTator, text mining | PubMed |
| CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. | J Exp Clin Cancer Res | 2022 | 35945614 | PubTator, text mining | PubMed |
| Integrative small and long RNA omics analysis of human healing and nonhealing wounds discovers cooperating microRNAs as therapeutic targets. | Elife | 2022 | 35942686 | PubTator, text mining | PubMed |
| Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest. | Front Pharmacol | 2022 | 35910374 | PubTator, text mining | PubMed |
| Anthraquinones and Their Analogues from Marine-Derived Fungi: Chemistry and Biological Activities. | Mar Drugs | 2022 | 35892942 | PubTator, text mining | PubMed |
| Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century. | Pharmaceuticals (Basel) | 2022 | 35890163 | PubTator, text mining | PubMed |
| A Possible Cause for the Differential Expression of a Subset of miRNAs in Mesenchymal Stem Cells Derived from Myometrium and Leiomyoma. | Genes (Basel) | 2022 | 35885889 | PubTator, text mining | PubMed |
| CDI Exerts Anti-Tumor Effects by Blocking the FoxM1-DNA Interaction. | Biomedicines | 2022 | 35884976 | PubTator, text mining | PubMed |
| Excessive activation of HOXB13/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance. | Biochem Biophys Res Commun | 2022 | 35878427 | PubTator, text mining | PubMed |
| Identification of Molecular Targets and Potential Mechanisms of Yinchen Wuling San Against Head and Neck Squamous Cell Carcinoma by Network Pharmacology and Molecular Docking. | Front Genet | 2022 | 35873484 | PubTator, text mining | PubMed |
| Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents. | BMC Cancer | 2022 | 35841085 | PubTator, text mining | PubMed |
| Altered Regulation of mRNA and miRNA Expression in Epithelial and Stromal Tissue of Keratoconus Corneas. | Invest Ophthalmol Vis Sci | 2022 | 35816043 | PubTator, text mining | PubMed |
| A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection. | Sci Rep | 2022 | 35794133 | PubTator, text mining | PubMed |
| The Anti-Glioma Effect of Juglone Derivatives through ROS Generation. | Front Pharmacol | 2022 | 35774612 | PubTator, text mining | PubMed |
| Human Cytomegalovirus Induced Aberrant Expression of Non-coding RNAs. | Front Microbiol | 2022 | 35770158 | PubTator, text mining | PubMed |
| Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials. | Cancer Treat Rev | 2022 | 35759856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=14